CDH Investments is an international alternative asset fund manager based in Hong Kong, China, with over $27 billion in assets under management. Founded in 2002 by the former private equity group of China International Capital Corporation, the firm has developed into a diversified platform that encompasses private equity, venture capital, growth capital, real assets, mezzanine financing, public equities, and wealth management. CDH Investments focuses on investing in various sectors, including consumer goods, hard technology, new energy, and healthcare. The firm is managed by a seasoned team of private equity professionals who have extensive experience in the Chinese market, enabling CDH to consistently deliver superior returns relative to its industry peers.
1503 International Commerce Center, 1 Austin Road West, Kowloon, Hong Kong / 25th Floor, Fortune Financial Center, 5 Dong san huan Central Road, Chaoyang District, Beijing, China 100020
Paul Chou
Managing Director
Liu Dan
Senior Partner
Xie Fang
Managing Director
Zhang Haifeng
Partner
William Hsu
Managing Director
Jason Hu
Managing Director of Mezzanine and Credit
Hu Xiaoling
Managing Director
Max Hui
Managing Partner
Gao Jieliang
Senior Partner
Li Lei
Managing Director
Escamillo Lin
Executive Director
Wu Minfeng
Managing Director
Charles Ren
Managing Partner
Jiao Shuge
Co-Founder and CEO
Wang Lin Ph.D
Co-Founder and Managing Director
Zhenyu Wang
Co-Founding Partner and Managing Director
Wang Mei
Managing Partner
Wang Mingyu
Senior Partner
John Wong
Managing Director
Wu Shangzhi
Chairman
Fan Yang
Managing Director
Ying Wei ch
Managing Director and Operating Partner
Ren Yiqiao
Managing Director
291 past transactions
Zelos
Series B in 2025
Zelos is an AI-driven startup is the way in autonomous driving technology. Its primary focus is on developing software and hardware that is centered around AI. Zelos offers intra-city autonomous transportation technologies, infrastructure, and optimal business models.
Tejin Intelligence
Series B in 2025
Tejin Intelligence is deeply involved in radio sensing and spectrum big data analysis technology, and is dedicated to providing the world's leading low-altitude safety management and control solutions, assisting in the development of new ground-air integrated three-dimensional security infrastructure for smart cities, and striving for refined management of urban low-altitude airspace.
Zhongtiansheng New Materials
Series A in 2025
Zhongtiansheng New Materials is a polyimide monomer and resin production company. It also manufactures resin material composites and liquid crystal orientation agents.
Mianbi Smart
Venture Round in 2024
Mianbi Smart enables large-scale model acceleration and application execution using artificial intelligence.
Zelos
Series B in 2024
Zelos is an AI-driven startup is the way in autonomous driving technology. Its primary focus is on developing software and hardware that is centered around AI. Zelos offers intra-city autonomous transportation technologies, infrastructure, and optimal business models.
Weimai Medical
Series A in 2024
Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Yida Technology
Series B in 2024
Yida Technology is engaged in technologies to create digital robots, empower users to realize business hyper-automation and build a future digital intelligence world. It has original and self-developed core technologies in related fields such as digital robots, artificial intelligence, and big data mining.
Huantian Wisdom
Series B in 2024
Huantian Wisdom specializes in providing integrated smart city solutions that encompass both satellite and ground technologies. The company focuses on developing environmentally friendly infrastructure, particularly smart street lighting systems aimed at enhancing urban sustainability. By offering innovative solutions, Huantian Wisdom aims to create a sustainable smart city ecology that benefits urban residents through improved infrastructure and energy efficiency.
CuPure Biotechnology
Seed Round in 2024
CuiPure Biotechnology is a developer of purification processes and materials for cell gene therapy, overcoming technical difficulties in molds, fluid mechanics, material synthesis, and bioengineering. They aim to improve resolution, binding capacity, processing speed, and filler costs for large-scale industrial purification.
OxSyns Biotech
Series A in 2024
OxSyns Biotech specializes in chemical synthesis and bioelectrochemical sensing for the chemical industry.
Ruijiakang
Series A in 2024
Ruijiakang focuses on the research, development, and application of green synthetic biology production, as well as the layout and research of biofuels and biomaterials for non-grain anaerobic organic alkyd pipelines, and employs Zymomonas mobilis.
Bach Hoa Xanh
Secondary Market in 2024
Bach Hoa Xanh is a chain of minimarts and food stores that concentrate in fresh produce and everyday household necessities.
PRCXI Biotechnology
Seed Round in 2024
PRCXI Biotechnology is a biotech company that provides bioinformatics and automation solutions for life science and the manufacturing of analytical instruments.
CYGNUSEMI
Series B in 2024
Cygnus Semi is a semiconductor chip technology company that specializes in developing solutions for 5G Internet-of-Things (IoT) applications. The company focuses on creating advanced connectivity capabilities for smart devices and smart cities. Its products are designed to enhance the performance of electronic devices, allowing manufacturers to integrate high-quality chip technology into their smart products. Through its innovations, Cygnus Semi aims to support the growing demand for enhanced connectivity in various sectors.
Curium Strontium
Venture Round in 2024
Curium Strontium is a CNC machine tool equipment developer that specializes in R&D, production, and sales of CNC machines. It also offers samples such as cover electrodes, shell models, micro-hole precision machining, bowl-shaped turning components, and graphite processing, and is dedicated to supplying industry users with associated gear, equipment, and services.
Weimai Medical
Series A in 2024
Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Volant Aerotech
Series A in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
Yuansuan Technology
Series C in 2024
Yuansuan Technology specializes in enhancing the digital research and development processes for industrial goods and optimizing the digital management and maintenance of facilities and equipment through local simulation software. Additionally, the company offers cloud architecture technology and services tailored for enterprise clients in various sectors, including automobile transportation, energy and electric power, hydraulic and emergency response, and machinery manufacturing. Their solutions are designed to improve cloud operation efficiency, providing clients with cloud entry services and comprehensive support in cloud operation and maintenance.
Greenon Biotech
Seed Round in 2024
Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Snow Tech
Seed Round in 2024
Snow Tech specializes in providing digital security products and services tailored for enterprise cybersecurity. The company develops a network security access architecture that employs a three-in-one service model focused on product, security, and operational guarantees. Its offerings encompass four core functions: context dynamic strategy, asset threat analysis, data security protection, and abnormal behavior analysis. These solutions enable enterprises to safeguard their digital assets, defend against external threats, and identify internal anomalies, thereby enhancing overall security and operational integrity. Snow Tech supports both local and Software as a Service (SaaS) deployments, ensuring flexibility in meeting diverse client needs.
Corerain Technologies
Series C in 2023
Corerain is an artificial intelligence company. They provide a next generation computing platform with integrated software and hardware development stacks to accelerate AI deployment in smart cities, aerospace, and smart manufacturing.
HemaCell
Series A in 2023
Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish a platform using platelet cells as a drug delivery carrier.
Gewei Semiconductor
Series B in 2023
Gewei Semiconductor is a manufacturer of efficient analog and analog-digital hybrid chips. It focuses mainly on the design and development of automotive-grade electric vehicle-specific chips.
Spear Bio
Seed Round in 2023
Spear Bio is a biotechnology company established in 2021 and located in Weston, Massachusetts. The company specializes in ultrasensitive protein detection technology, which provides significant advantages in the healthcare sector. Its innovations support self-testing and telemedicine-based diagnostics by enabling the quantification of minute protein biomarkers from samples collected at home. This approach allows clinicians to achieve ultrasensitive detection using small sample volumes, seamlessly integrating into existing workflows for sample collection, processing, and analysis.
Weiling Medical
Angel Round in 2023
Wiling Medical offers extensive knowledge of the principles and clinical uses of implantable brain-computer interfaces as well as extensive experience in basic research engineering practise, and clinical care.
JUYOU Bio-tech
Angel Round in 2023
JUYOU Bio is a company that specializes in the creation, manufacture, and distribution of synthetic biological raw materials, biomedical materials, and dermatology-grade skin care products. It focuses on providing precise and effective skin care treatments.
Weixin New Materials
Series C in 2023
Weixin New Materials specializes in the manufacturing and research of photoresist resins and electronic-grade monomers. The company is dedicated to producing high-purity, cost-effective, and environmentally-friendly materials specifically designed for the semiconductor industry. By focusing on advanced materials for photoresists and supporting applications, Weixin New Materials aims to meet the growing demands of its clients while ensuring quality and sustainability in its product offerings.
Frebang
Series B in 2023
Frebang is a company specializing in the research, development, and manufacturing of advanced nanomaterials for various high-end applications. It produces a range of innovative products, including nanofiber-based filtration materials, antibacterial air purification solutions, and flexible ceramic nanofibers designed for high-temperature insulation. The company's offerings cater to diverse industries such as semiconductors, biomedicine, lithium batteries, and aerospace, as well as outdoor clothing. By focusing on high-efficiency filtration and advanced material solutions, Frebang aims to address the specific needs of industrial users, ensuring effective performance and reliability in demanding environments.
Shenzhen Jianwang Technology
Series A in 2023
Shenzhen Jianwang Technology is a high-tech enterprise dedicated to the development and manufacture of smart energy solutions, particularly in the realm of power electronics. The company specializes in smart grid technology and focuses on the research and production of charging pile power modules and both AC and DC charging piles. In addition to these products, Jianwang Technology provides comprehensive services related to the operation and maintenance of charging stations, as well as high-end power supply customization services. Through its innovative approach, the company aims to contribute significantly to the new energy sector.
Formal-Tech
Series A in 2023
Formal-Tech is an embedded system software company that specializes in the development, production, and sales of high-safety industrial control software and hardware.
Jiemeng Intelligence
Venture Round in 2023
Jiemeng Intelligence specializes in the development, design, and manufacturing of lithium-ion battery coating equipment. The company is dedicated to creating front-end equipment and machinery specifically for the lithium-ion battery industry. By focusing on innovative solutions, Jiemeng Intelligence aims to provide clients with safe, efficient, and intelligent new energy equipment that meets the growing demands of the market.
Enigma
Series A in 2023
Enigma is an innovative technology company dedicated to providing safe, reliable, and advanced solutions for industrial intelligent manufacturing.
Xincheng Semiconductor
Seed Round in 2023
Xincheng Semiconductor manufactures integrated circuit packaging substrates. Semiconductor is a provider of integrated circuit packaging substrate solutions. It focuses on the research and development and mass manufacture of high-density flip-chip packaging substrates, filling a gap in domestic high-end substrates and assisting the domestic semiconductor industry chain in becoming autonomous and controllable.
Mucheng Fireproof
Series A in 2023
Mucheng is a high-tech chemical enterprise focuses on special materials such as cutting-edge fire prevention, fire resistance and heat insulation.
Lanhai Energy
Seed Round in 2023
Lanhai Energy is a new energy storage solution provider that assists customers in achieving their ESG objectives. They provide commercial-scale ESS and EVCS systems that are distinguished by innovation and advanced technologies.
Acchrom
Series A in 2023
Acchrom, operating under Huapu Instrument (Beijing) Technology Co., Ltd., specializes in chromatographic separation products, offering comprehensive solutions that include equipment, consumables, software, and technical services. The company aims to establish itself as a leading national brand in chromatography by developing targeted marketing strategies and building a professional marketing network across key provinces. Acchrom's focus on the complete chromatography process enables clients to effectively analyze and separate mixtures, positioning the company as a significant player in the field.
Edrive Space
Series B in 2023
Edrive Space specializes in developing advanced aerospace propulsion systems aimed at enhancing the aerospace industry, particularly in China. The company focuses on electrothermal micro-propulsion technologies that address the limitations of traditional electric propulsion systems, such as excessive weight, high power requirements, and low thrust. Their products are designed for the efficient orbiting and networking of micro-nano satellites, making them suitable for applications like emergency collision avoidance of space debris and active deorbiting. Edrive Space's solutions cater to the growing demand for low-cost, standardized, and scalable propulsion systems in the commercial satellite sector, positioning the company as a key player in the evolving landscape of satellite technology.
Ai Ma Biology
Angel Round in 2023
Ai Ma Biology is a small RNA nucleic acid drug developer, dedicated to the transformation of achievements in the field of biosynthesis.
Hualong
Series A in 2023
Hualong is an industrial Internet empowerment platform that offers benefits in the realm of digital twins at the equipment, plant, and industrial levels.
Mingxin Digital
Series A in 2023
Mingxin Digital is a financial technology company focused on enhancing industrial credit management through digital solutions. It has developed a corporate credit evaluation management SaaS platform that serves as a management tool for assessing business operations. This platform aims to improve operational efficiency and enhance risk management capabilities for corporations, allowing them to better navigate financial challenges and make informed decisions. By leveraging digital technology, Mingxin Digital seeks to transform traditional credit management practices in the industry.
Keyang Semiconductor
Venture Round in 2023
Keyang Semiconductor specializes in the design, research and development, manufacturing, packaging, and testing of semiconductor products, particularly focusing on TSV (Through-Silicon Via) package integrated circuits. The company is committed to advancing the semiconductor industry by providing comprehensive wafer-level packaging and testing services. Keyang aims to deliver innovative solutions, including WLCSP (Wafer-Level Chip Scale Package) and bumping technologies, to meet the diverse needs of its clients. Through its extensive expertise and capabilities, Keyang Semiconductor plays a significant role in promoting the development of advanced semiconductor technologies.
Yida Technology
Series B in 2023
Yida Technology is engaged in technologies to create digital robots, empower users to realize business hyper-automation and build a future digital intelligence world. It has original and self-developed core technologies in related fields such as digital robots, artificial intelligence, and big data mining.
Jinfang Pharmaceutical
Series C in 2023
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.
Jidian Solar
Series A in 2023
Jidian Solar provides semiconductor materials and devices. They also provide research and development of perovskite technology services. Additionally, they also provide promoting energy transformation services.
Neomodulus
Series B in 2023
Nuoyimeier is a developer of implantable consumables.
Weiling Medical
Angel Round in 2023
Wiling Medical offers extensive knowledge of the principles and clinical uses of implantable brain-computer interfaces as well as extensive experience in basic research engineering practise, and clinical care.
Jinjing Keji
Series A in 2022
Jinjing Keji manufactures cathode fluorescence system products. They are mainly in scientific research institutes, semiconductor industry, and electron microscope manufacturing. They provide testing services too in addition to selling the product.
Well-Link Tech
Series B in 2022
Well-Link is a cloud rendering solutions provider with headquarters in Singapore.
Jiemeng Intelligence
Seed Round in 2022
Jiemeng Intelligence specializes in the development, design, and manufacturing of lithium-ion battery coating equipment. The company is dedicated to creating front-end equipment and machinery specifically for the lithium-ion battery industry. By focusing on innovative solutions, Jiemeng Intelligence aims to provide clients with safe, efficient, and intelligent new energy equipment that meets the growing demands of the market.
Cims
Private Equity Round in 2022
CIMS provides automated optical inspection solutions dedicated to enhancing production processes and yield in Printed Circuit Board (PCB), High Density Interconnect PCB (HDI PCB), Flex and Rigid-flex PCB and IC Substrates.CIMS addresses specific needs of all segments of PCB manufacturing industry with dedicated solutions based on advanced imaging and image processing technologies. CIMS solutions are applied to wide range of applications across those segments at multiple stages of PCB manufacturing process.
Airgram
Series A in 2022
An Airgram is a real-time transcription with speaker identification and high-definition video recording.
Chuangjian Medical
Series A in 2022
Chuangjian Medical is a technological innovation company that focuses on the creation, sale, and research & development of novel protein- and nucleic acid-based medicines.
Qingxin Technology
Series A in 2022
Zhejiang Qingxin is a manufacturer of semiconductor testing and sorting machines. It is involved in the research, development, and manufacture of most semiconductor automation equipment, with a focus on testing and packaging handling solutions.
TargetRx
Series B in 2022
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.
Style3D
Series B in 2022
Style3D is a software and service ecosystem for all fashion that enables designers and businesses to work on real-time 3D simulation outperforming their productivity and creativity while reaching higher sustainability.
TSC
Venture Round in 2022
Xinjinghe Laser Technology Development (Beijing) Co., Ltd. is a company that focuses on high-end manufacturing industries such as aerospace, navigation, and nuclear power. It specializes in complicated metal component customisation, product design and optimization, and software customization. Development and sales, technical advice and services, product remanufacturing and repair, 3D printing equipment manufacturing and sales of national high-tech businesses, is China's leading provider of metal additive/subtractive manufacturing technology comprehensive solutions.
ADA Intelligent Equipment
Series B in 2022
ADA Intelligent Equipment focuses on the development of semiconductor packaging equipment and automation solutions. The company offers a range of products, including high-precision semiconductor die bonders, flip-chip bonders, ball bonders, and wafer-level packaging equipment. Additionally, it provides panel packaging equipment and microLED mass transfer equipment, catering to the evolving needs of the semiconductor industry. Through its advanced technology, ADA Intelligent Equipment aims to enhance efficiency and precision in semiconductor manufacturing processes.
Qingyun Zhitong
Series B in 2022
Qingyun Zhitong is an intelligent manufacturing enabling enterprise in the chemical industry. It is a continuous transformation platform for the scientific and technological achievements of the department of chemical engineering and the department of automation of tsinghua university. The company is committed to empowering industrial big data technology, industrial intelligent control technology, 5G technology, and AI technology. It can help chemical industry parks and chemical enterprises to help the construction of new infrastructure and industrial Internet in the chemical industry, and promote the intelligent transformation and upgrading of chemical enterprises and the construction of intelligent factories.
CSR Biotech
Seed Round in 2022
CSR Biotech is a biological research company that specializes in super-resolution imaging technologies for living cells. The company focuses on the research, development, and manufacturing of advanced imaging instruments, providing a range of services such as customized cell sample generation, high-throughput detection, and imaging studies. Additionally, CSR Biotech offers image post-processing and quantitative analysis, along with high-dimensional spatio-temporal data visualization. These services are designed to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby enhancing the capabilities of scientific exploration in the field of biotechnology.
Scientech Medical
Venture Round in 2022
Scientech Medical engages in the research, development, and manufacturing of interventional medical devices.
Tessera Therapeutics
Series C in 2022
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
ThreatBook
Series E in 2022
ThreatBook, founded in 2015, specializes in cyber threat detection and response by providing high-fidelity security intelligence and integrated threat detection systems. The company utilizes machine learning to analyze and report cyber threat data, assisting enterprises in protecting their cloud, network, and endpoints. By enhancing the efficiency of threat response and simplifying security operations, ThreatBook serves customers across various sectors, including finance, energy, intelligent manufacturing, and the internet. The firm has gained recognition in the cybersecurity industry, being noted on the Cybersecurity 500 list and consistently appearing in Gartner's Market Guide for Security Threat Intelligence Products and Services. Additionally, it achieved the top position in Frost & Sullivan's China Threat Intelligence Market Report and was acknowledged as a Strong Performer in Gartner Peer Insights' Voice of the Customer report for Network Detection and Response.
Aibo Medical Robot
Seed Round in 2022
Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
UniXell Biotechnology
Seed Round in 2022
UniXell Biotechnology is a developer of cell therapies utilizing human pluripotent stem cell technology. The company focuses on addressing unmet medical needs in neurodegenerative diseases, rare diseases, and tumors. UniXell has established multiple key technology platforms, including reprogramming technology, stem cell differentiation, SISBAR pedigree tracing technology, and high-precision gene editing. These innovations enable the development of effective treatment solutions aimed at improving the lives of patients suffering from complex medical conditions. The company's proprietary intellectual property encompasses various aspects of stem cell preparation, cultivation, differentiation, and gene editing, positioning it as a leader in the advancement of cellular therapies.
UniXell
Seed Round in 2022
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
Dian Xiaomi
Series C in 2022
Dian Xiaomi is a e-commerce IT service company, focusing on providing SaaS system services for global e-commerce sellers, making it easier to "buy and sell globally". Dian Xiaomi gathers a strong domestic IT R&D team. The core members are from well-known companies such as Baidu, Tencent, and Meituan. They have 15+ years of experience in software research and development. Dian Xiaomi was established on March 26, 2014 by Jianyin Du in Longgang, Guangdong.
CYGNUSEMI
Series A in 2022
Cygnus Semi is a semiconductor chip technology company that specializes in developing solutions for 5G Internet-of-Things (IoT) applications. The company focuses on creating advanced connectivity capabilities for smart devices and smart cities. Its products are designed to enhance the performance of electronic devices, allowing manufacturers to integrate high-quality chip technology into their smart products. Through its innovations, Cygnus Semi aims to support the growing demand for enhanced connectivity in various sectors.
HemaCell
Seed Round in 2022
Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish a platform using platelet cells as a drug delivery carrier.
Innoscience
Series D in 2022
Innoscience is an 8-inch Integrated Device Manufacturer (IDM) that focuses on GaN technology. The company was founded in 2015 and is headquartered in Zhuhai, Guangdong, China.
Ai Ma Biology
Angel Round in 2022
Ai Ma Biology is a small RNA nucleic acid drug developer, dedicated to the transformation of achievements in the field of biosynthesis.
ReviR Therapeutics
Seed Round in 2022
ReviR Therapeutics is a genomics-focused company that develops innovative RNA-based medicines aimed at treating cancer, rare genetic disorders, and infectious diseases. The company leverages an artificial intelligence-driven platform to enhance the discovery of therapeutics that target human RNAs. By combining advanced computational techniques with genomic insights, ReviR Therapeutics strives to create transformative therapies that can significantly impact patient care and improve health outcomes for millions.
Qingyun Zhitong
Series A in 2022
Qingyun Zhitong is an intelligent manufacturing enabling enterprise in the chemical industry. It is a continuous transformation platform for the scientific and technological achievements of the department of chemical engineering and the department of automation of tsinghua university. The company is committed to empowering industrial big data technology, industrial intelligent control technology, 5G technology, and AI technology. It can help chemical industry parks and chemical enterprises to help the construction of new infrastructure and industrial Internet in the chemical industry, and promote the intelligent transformation and upgrading of chemical enterprises and the construction of intelligent factories.
Ceram Pharmaceuticals
Series A in 2022
Ceram Pharmaceuticals is a biotech firm that uses epigenetics to carry out R&D of drugs and diagnostic treatments for cancer and diseases.
Cloudbreak Therapeutics
Series C in 2022
Cloudbreak Therapeutics is a clinical-stage biotechnology company focusing on ocular drug development. Cloudbreak Therapeutics operates a capital efficient business model based upon VIC + 505b(2). We repurpose approved systemic drugs for ocular delivery to treat eye diseases and quickly advance drug candidates to complete proof-of-concept (POC) Phase II clinical trials and to out-license global rights for Phase III clinical trials, product registration, and commercialization. Fully embracing the pharmaceutical development ecosystem, we utilize contract research organizations (CRO) for non-clinical, CMC and clinical development to efficiently maximize capital for drug development.
Tianyi Hexin
Venture Round in 2022
Tianyi Hexin is a developer and designer of integrated circuits, focusing on analog, digital, hybrid, and radio frequency technologies. The company's product offerings encompass a range of integrated circuits, including heart rate sensors, wireless interconnect ICs, sensor front ends, data converters, ECG sensors, and Bluetooth chips. In addition to its core product development, Tianyi Hexin also provides technology consulting and intellectual property licensing services, enhancing its role in the semiconductor industry and supporting clients' various technological needs.
Yunli Smart Technology
Series A in 2021
Yunli Wisdom is a digital transformation service provider for government and enterprises. It uses cloud computing, big data, Internet of Things, artificial intelligence, and blockchain as its core technologies. It focuses on government affairs, finance, transportation, manufacturing, ecological environment and other fields, and is committed to providing Application software and services empowered by new technologies.
Thousand Oaks Biopharmaceuticals
Venture Round in 2021
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and located in Haimen, China, specializes in contract development and manufacturing services tailored for the biotechnology sector. The company focuses on developing biopharmaceutical technologies aimed at producing protein and vaccine compounds. It offers integrated control solutions that enhance production processes by optimizing protein expression and reducing production scale. This enables biopharmaceutical companies to access personalized, chemically-defined cell culture media, formula production, technical support, and ancillary services. By providing these comprehensive services, Thousand Oaks Biopharmaceuticals aims to facilitate the creation of accessible and affordable biologics to meet global healthcare needs.
Qixin Micro Semiconductor
Venture Round in 2021
Suzhou Qixin Micro Semiconductor Co., Ltd. was established in October 2020. Based on the ARM Cortex M4, M7 and other series of architectures, it will build high-performance and high-reliability system-on-chips for different automotive application scenarios, and develop high-end smart car controller chips. Through the use of self-developed IP, unique multi-core lock-step technologies, and the unique Six Sigma analog circuit design process for automotive-standard chips, a full series of product families covering safety standards ISO26262 ASIL-B to ASIL-D have been designed. The company's products all meet the automotive regulations AEC-Q100, functional safety standard ISO26262 and various automotive regulations reliability tests, and can be widely used in the fields of body, automotive instrumentation, safety, power, battery management and other fields. The company is mainly engaged in the research and development and sales of high-end automotive controller chips. The goal is to fill the gap in the domestic new generation of intelligent networked automotive controller chips, and is committed to becoming a leading manufacturer in the field of automotive and industrial controllers in China.
Guizhou Core Long March Technology (Marching Power)
Series C in 2021
Guizhou Core Long March Technology, also known as Marching Power, is a high-tech company focused on the development of power semiconductor devices. Its product portfolio includes IGBT, coolmos, and SiC chip technologies, which are designed to operate under varying temperatures and voltages. The company's technical team comprises experts from the Chinese Academy of Sciences and skilled professionals from abroad, boasting substantial experience in product development. They oversee the entire process from chip design to manufacturing, packaging, testing, and reliability. Additionally, the company has a proficient marketing and operations management team well-versed in the semiconductor industry. Through its commitment to localizing power chip production, Guizhou Core Long March Technology aims to enable various enterprises to integrate high-quality semiconductors into their electronic products effectively.
SVOLT
Series B in 2021
SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energy vehicle charging piles, batteries recycling, and solutions.
Well-Link Tech
Series B in 2021
Well-Link is a cloud rendering solutions provider with headquarters in Singapore.
WELINK
Series B in 2021
Well-Link is a domestic provider of video cloud solutions. Its core technical team is a pioneer in the field of cloud games in China, with over ten years of research experience in the field. Console games, online games, Android games, and so on can all easily enter the cloud. Weiling Times has begun extensive collaboration with a number of leading domestic cloud server providers. Weiling cloud game solutions can be deployed quickly and efficiently regardless of the cloud server used.
Vision Medicals
Series D in 2021
Vision Medicals specializes in pathogenic gene diagnostic services, aiming to enhance medical treatment precision for infections. The company utilizes advanced technologies such as high-throughput sequencing-based pathogen metagenomics and CRISPR for rapid diagnostics, significantly improving the ability to detect clinical pathogens and reducing reporting times. Vision Medicals has developed proprietary nucleic acid enrichment technology to identify pathogenic micronucleic acids in clinical samples. By leveraging an extensive database of pathogen detection, the company has established a comprehensive pathogen macro, supported by a genomics intelligent analysis and reporting system. Through its focus on research and development, Vision Medicals seeks to lead the medical diagnostic industry with innovative detection technology platforms that enhance the efficiency and accuracy of medical diagnoses.
Changmugu Medical
Series B in 2021
Beijing Changmugu Medical Technology Co., Ltd. is a healthcare startup specializing in artificial intelligence-powered solutions for orthopedic surgery. The company focuses on enhancing the accuracy and safety of surgical procedures through advanced technologies, including AI-assisted diagnosis and individualized operation plans. Additionally, it offers 3D printing patient-specific instrumentation (PSI) for surgical navigation and post-operative intelligent evaluation services. By leveraging AI deep learning, Changmugu Medical aims to provide innovative tools that improve patient outcomes and streamline surgical processes, ultimately contributing to safer and more stable operations in the field of orthopedics.
Singleron Biotechnologies
Series B in 2021
Singleron Biotechnologies Ltd. is a molecular diagnostic company specializing in single cell sequencing solutions. Founded in 2018 and based in Nanjing, China, with additional offices and laboratories in Suzhou, the United States, and Germany, the firm develops a range of innovative products, including the Singleron Matrix automated instrument for high-density microwell processing and GEXSCOPE single cell RNA sequencing kits. The company also offers a microfluidic chip for cell partitioning, magnetic beads for cell barcoding, and tools for data analysis such as CeleScope and SynEcoSys, which facilitate the interpretation of single cell sequencing data. Singleron provides services in single cell RNA sequencing, single nucleus RNA sequencing, and bioinformatics analysis, aiming to advance clinical diagnosis, drug development, and health management. The company collaborates with research institutes, hospitals, and pharmaceutical firms primarily in China and the United States, leveraging its exclusive IP license from Yale University to enhance its innovative capabilities in single cell analysis.
LaiHua
Series C in 2021
LaiHua is a creative design platform for presentation and animation video creation.
IASO Biotherapeutics
Series C in 2021
Nanjing IASO Biotherapeutics is a clinical stage biotechnology company established in 2017 and located in Nanjing, China. The company specializes in the discovery, development, and commercialization of innovative therapies aimed at treating cancer. IASO Biotherapeutics is particularly focused on engineered autologous and allogenic T cell therapies, which are designed to enhance the immune system's capability to identify and eliminate cancer cells. Through its research and development efforts, the company aims to provide effective cancer treatments that leverage the body's own immune response.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.